Arialys Therapeutics is developing new precision medicines to specifically block the effect of pathogenic autoantibodies in the brain, expanding treatment possibilities for neuropsychiatric disorders driven by autoimmune disease
Arialys Therapeutics is developing new precision medicines to specifically block the effect of pathogenic autoantibodies in the brain, expanding treatment possibilities for neuropsychiatric disorders driven by autoimmune disease.